174 related articles for article (PubMed ID: 32923859)
1. DNA Methylation Profiling Reveals Prognostically Significant Groups in Pediatric Adrenocortical Tumors: A Report From the International Pediatric Adrenocortical Tumor Registry.
Clay MR; Pinto EM; Cline C; Tran QT; Lin T; Dyer MA; Shi L; Wu H; Pounds SB; Zambetti GP; Orr BA; Ribeiro RC
JCO Precis Oncol; 2019; 3():. PubMed ID: 32923859
[TBL] [Abstract][Full Text] [Related]
2. Targeted Assessment of
Mohan DR; Lerario AM; Else T; Mukherjee B; Almeida MQ; Vinco M; Rege J; Mariani BMP; Zerbini MCN; Mendonca BB; Latronico AC; Marie SKN; Rainey WE; Giordano TJ; Fragoso MCBV; Hammer GD
Clin Cancer Res; 2019 Jun; 25(11):3276-3288. PubMed ID: 30770352
[TBL] [Abstract][Full Text] [Related]
3. Identification of a CpG island methylator phenotype in adrenocortical carcinomas.
Barreau O; Assié G; Wilmot-Roussel H; Ragazzon B; Baudry C; Perlemoine K; René-Corail F; Bertagna X; Dousset B; Hamzaoui N; Tissier F; de Reynies A; Bertherat J
J Clin Endocrinol Metab; 2013 Jan; 98(1):E174-84. PubMed ID: 23093492
[TBL] [Abstract][Full Text] [Related]
4. Weineke criteria, Ki-67 index and p53 status to study pediatric adrenocortical tumors: Is there a correlation?
Das S; Sengupta M; Islam N; Roy P; Datta C; Mishra PK; Banerjee S; Chaudhuri MK; Chatterjee U
J Pediatr Surg; 2016 Nov; 51(11):1795-1800. PubMed ID: 27567308
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation is a comprehensive marker for pediatric adrenocortical tumors.
Bueno AC; da Silva RMP; Stecchini MF; Marrero-Gutiérrez J; de Almeida E Silva DC; Cardinalli I; Scrideli CA; Junqueira T; Molina CAF; Ramalho FS; Tucci S; Coeli-Lacchini FB; Moreira AC; Ramalho LNZ; Brandalise S; Yunes JA; de Castro M; Vêncio RZN; Antonini SRR
Endocr Relat Cancer; 2022 Nov; 29(11):599-613. PubMed ID: 36040817
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of Wieneke criteria in assessing morphologic characteristics of adrenocortical tumors in children.
Chatterjee G; DasGupta S; Mukherjee G; Sengupta M; Roy P; Arun I; Datta C; Mishra PK; Banerjee S; Chatterjee U
Pediatr Surg Int; 2015 Jun; 31(6):563-71. PubMed ID: 25895073
[TBL] [Abstract][Full Text] [Related]
7. Pediatric adrenocortical tumors: morphological diagnostic criteria and immunohistochemical expression of matrix metalloproteinase type 2 and human leucocyte-associated antigen (HLA) class II antigens. Results from the Italian Pediatric Rare Tumor (TREP) Study project.
Magro G; Esposito G; Cecchetto G; Dall'Igna P; Marcato R; Gambini C; Boldrini R; Collini P; D'Onofrio V; Salfi N; d'Amore E; Ferrari A; Bisogno G; Alaggio R
Hum Pathol; 2012 Jan; 43(1):31-9. PubMed ID: 21820153
[TBL] [Abstract][Full Text] [Related]
8. Identification of Clinical and Biologic Correlates Associated With Outcome in Children With Adrenocortical Tumors Without Germline TP53 Mutations: A St Jude Adrenocortical Tumor Registry and Children's Oncology Group Study.
Pinto EM; Rodriguez-Galindo C; Pounds SB; Wang L; Clay MR; Neale G; Garfinkle EAR; Lam CG; Levy CF; Pappo AS; Zambetti GP; Ribeiro RC
J Clin Oncol; 2017 Dec; 35(35):3956-3963. PubMed ID: 29058986
[TBL] [Abstract][Full Text] [Related]
9. Pediatric Adrenocortical Neoplasms: A Study Comparing Three Histopathological Scoring Systems.
Jangir H; Ahuja I; Agarwal S; Jain V; Meena JP; Agarwala S; Sharma R; Sharma MC; Iyer VK; Mani K
Endocr Pathol; 2023 Jun; 34(2):213-223. PubMed ID: 37160532
[TBL] [Abstract][Full Text] [Related]
10. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry.
Michalkiewicz E; Sandrini R; Figueiredo B; Miranda EC; Caran E; Oliveira-Filho AG; Marques R; Pianovski MA; Lacerda L; Cristofani LM; Jenkins J; Rodriguez-Galindo C; Ribeiro RC
J Clin Oncol; 2004 Mar; 22(5):838-45. PubMed ID: 14990639
[TBL] [Abstract][Full Text] [Related]
11. DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical Cancer.
Jouinot A; Assie G; Libe R; Fassnacht M; Papathomas T; Barreau O; de la Villeon B; Faillot S; Hamzaoui N; Neou M; Perlemoine K; Rene-Corail F; Rodriguez S; Sibony M; Tissier F; Dousset B; Sbiera S; Ronchi C; Kroiss M; Korpershoek E; de Krijger R; Waldmann J; K D; Bartsch ; Quinkler M; Haissaguerre M; Tabarin A; Chabre O; Sturm N; Luconi M; Mantero F; Mannelli M; Cohen R; Kerlan V; Touraine P; Barrande G; Groussin L; Bertagna X; Baudin E; Amar L; Beuschlein F; Clauser E; Coste J; Bertherat J
J Clin Endocrinol Metab; 2017 Mar; 102(3):923-932. PubMed ID: 27967600
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.
Shen C; Liu J; Yang X; Jiao W; Wang Y
Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753
[TBL] [Abstract][Full Text] [Related]
13. Adrenocortical tumors in children.
Ciftci AO; Senocak ME; Tanyel FC; Büyükpamukçu N
J Pediatr Surg; 2001 Apr; 36(4):549-54. PubMed ID: 11283875
[TBL] [Abstract][Full Text] [Related]
14. Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults.
Faria AM; Almeida MQ
Mol Cell Endocrinol; 2012 Mar; 351(1):52-7. PubMed ID: 22019901
[TBL] [Abstract][Full Text] [Related]
15. Methylation of IGF2 regulatory regions to diagnose adrenocortical carcinomas.
Creemers SG; van Koetsveld PM; van Kemenade FJ; Papathomas TG; Franssen GJ; Dogan F; Eekhoff EM; van der Valk P; de Herder WW; Janssen JA; Feelders RA; Hofland LJ
Endocr Relat Cancer; 2016 Sep; 23(9):727-37. PubMed ID: 27535174
[TBL] [Abstract][Full Text] [Related]
16. Pediatric adrenal cortical carcinomas: Histopathological criteria and clinical trials. A systematic review.
Xu X; Sergi C
Contemp Clin Trials; 2016 Sep; 50():37-44. PubMed ID: 27424218
[TBL] [Abstract][Full Text] [Related]
17. Clinical Impact of Pathological Features Including the Ki-67 Labeling Index on Diagnosis and Prognosis of Adult and Pediatric Adrenocortical Tumors.
Martins-Filho SN; Almeida MQ; Soares I; Wakamatsu A; Alves VAF; Fragoso MCBV; Zerbini MCN
Endocr Pathol; 2021 Jun; 32(2):288-300. PubMed ID: 33443677
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors.
Fonseca AL; Kugelberg J; Starker LF; Scholl U; Choi M; Hellman P; Åkerström G; Westin G; Lifton RP; Björklund P; Carling T
Genes Chromosomes Cancer; 2012 Oct; 51(10):949-60. PubMed ID: 22733721
[TBL] [Abstract][Full Text] [Related]
19. Prognosis and Therapeutic Efficacy Prediction of Adrenocortical Carcinoma Based on a Necroptosis-Associated Gene Signature.
Ji D; Zhong R; Fan S
Biomed Res Int; 2022; 2022():8740408. PubMed ID: 35647181
[TBL] [Abstract][Full Text] [Related]
20. Overview of the 2022 WHO Classification of Adrenal Cortical Tumors.
Mete O; Erickson LA; Juhlin CC; de Krijger RR; Sasano H; Volante M; Papotti MG
Endocr Pathol; 2022 Mar; 33(1):155-196. PubMed ID: 35288842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
